Ceva Santé Animale Reinforces Its Production Capacity

FRANCE - Ceva Santé Animale has invested €18 million in renovating and extending its sterile products plant in Libourne. The new industrial facility was inaugurated on 3 October and will increase injectable drug production capacity.
calendar icon 3 November 2014
clock icon 2 minute read

Driving innovation is the key factor behind Ceva Santé Animale's pharmaceutical strategy and to meet the demand of future growth, the global veterinary health group invested €18 million in renovating and extending the controlled atmosphere production areas at its pharmaceutical plant in Libourne.

After two and a half years of work carried out without shutting down existing production facilities, an extension of 500 square metres has now been completed, along with the renovation of 1,000 square metres of existing floor areas and installation of new manufacturing and filling equipment.

This plant for the future has been designed to allow Ceva the possibility of making further developments in line with changes in product demand and pharmaceutical regulations.

You can find out more by visiting www.thepigsite.com/swinenews/37895/ceva-sant-animale-reinforces-its-production-capacity.

Contact: Web site: www.ceva.com.

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.